Prebona (PREBON) Q3 2025 earnings summary

Executive summary

• Q3 2025 marked a turning point with resumed growth after a challenging period, driven by sales initiatives, international expansion, and new partnerships.

• Notable customer inflow and distributor agreements in Europe and Asia, especially in HealthCare and AirCare segments.

• Strategic focus on sales, profitability, and long-term partnerships is expected to support continued growth into 2026.

Financial highlights

• Q3 2025 net sales were SEK 1,185,086, up from SEK 1,028,342 year-over-year.

• Operating income for Q3 was SEK 1,190,435 (Q3 2024: SEK 1,067,622).

• Result after financial items for Q3 improved to SEK -1,177,687 (Q3 2024: SEK -2,149,871).

• Cash flow from operations in Q3 was SEK -848,491 (Q3 2024: SEK -616,361).

• EPS for Q3 was SEK -0.04 (Q3 2024: SEK -0.07); for Jan–Sep 2025, SEK -0.18 (Jan–Sep 2024: SEK -0.20).

• Net sales for Jan–Sep 2025 were SEK 2,318,578, down from SEK 4,555,177 year-over-year.

• Result after financial items for Jan–Sep 2025 was SEK -5,741,269 (Jan–Sep 2024: SEK -5,865,150).

Outlook and guidance

• Sales increases are expected in coming quarters due to ongoing sales activities and product commercialization.

• Management believes available liquidity, recent capital raises, and new commitments will fund operations for the next 12 months, though targeted strategic initiatives may require additional financing.

• 2026 is anticipated to be a year of clear turnaround and growth.